Sources
Loading...
Additional media
Loading...

British vaccine start-up Baseimmune raises a total of £23 million in venture capital funding to develop AI-boosted adaptable vaccines for future pathogen mutations and pandemics. The company aims to leverage AI technology for innovative vaccine development.
Startup uses AI to develop vaccines for future pandemics https://t.co/mA4SIVYYrm
This one might be complicated for those tech optimists who also are vax skeptics... Startup uses AI to develop vaccines for future pandemics https://t.co/zce1POCfHl
Baseimmune, a British startup that uses AI to develop vaccines for future pathogen mutations, raised £9 million in venture capital funding. https://t.co/Kg2refMlCG




